While evidence for the same mechanism occurring in human mCRPC still need to be provided, these preliminary findings suggest a role for aerobic glycolysis in PCa progression/CR establishment and support the exploration of targeting LDHA and MCT transporters as new therapeutic opportunities for mCRPC, as discussed below. This evidence concerns the gene LDHA and posterior cortical atrophy.